Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The drug targets a protein that suppresses tooth growth, aiming ...

This could be a game changer. The post Plans Accelerated for Human Trials of Tooth Regeneration appeared first on Futurism.

Tooth regrowth drug TRG035 is moving towards Phase II trials in patients with severe congenital hypodontia after new funding.

The Oplegnathus punctatus (O. punctatus) is an economically significant marine aquaculture species. It possesses a distinct beak-like tooth phenotype, allowing it to feed on hard-shelled foods such as ...

For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in genetics, molecular biology, and regenerative medicine, that dream is ...

Kyoto University Hospital launched the first human trial of an experimental drug named TRG-035. The initial safety study ...

A hypothetical model illustrating how reduced Hedgehog signaling alters interactions between the rudimentary tooth bud (R2) and the first molar (M1), leading to supernumerary (SN) tooth or molar ...

A novel study on the natural coordination of tooth development in time and space, led by Dr. Han-Sung Jung at the Yonsei University College of Dentistry, Korea, has discovered that "lingual" cells on ...

Two distinct stem cell lineages that drive tooth root and alveolar bone formation have been identified by researchers from Science Tokyo. Using genetically modified mice and lineage-tracing techniques ...